FDA increases control over laboratory-developed tests after

The FDA is now classifying LDTs as medical devices. This follows criticism following the FDA not approving COVID-19 rapid tests more quickly in 2020.

Related Keywords

United States , Americans , Jeff Shuren , Elizabeth Holmes , Robert Califf , Senate Health , Pensions Committee , Drug Administration , Bill Cassidy ,